Tachycardia is a condition in which the heart rate is abnormally fast. It can occur in both adults and children, and can be a sign of a serious underlying medical condition. In this article, we will explore the causes and treatments of tachycardia, providing a comprehensive guide for doctors.
Tachycardia is a condition in which the heart rate is abnormally fast. It is typically defined as a heart rate of greater than 100 beats per minute in adults, and greater than 180 beats per minute in children. It can be caused by a variety of factors, including medical conditions, certain medications, and lifestyle factors.
There are several types of tachycardia, each with its own underlying cause. The most common types include:
The underlying cause of tachycardia can vary depending on the type. Some of the most common causes include:
The most common symptom of tachycardia is a rapid or irregular heartbeat. Other symptoms may include:
Tachycardia is usually diagnosed by a doctor based on the patient's symptoms and medical history. The doctor may perform a physical exam and order tests, such as an electrocardiogram (ECG), to confirm the diagnosis. An ECG is a test that records the electrical activity of the heart. It can detect abnormal heart rhythms, such as tachycardia. The doctor may also order other tests, such as blood tests or an echocardiogram, to determine the underlying
1.
Prostate cancer Q&A: Improving detection and reducing overtreatment
2.
FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting
3.
A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.
4.
Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL
5.
New imaging technique identifies glioblastoma patients who would benefit from immunotherapy
1.
Understanding Villous Adenoma: Causes, Symptoms, and Treatments
2.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
3.
Generative AI for Adaptive Oncology Trial Design
4.
The Future is Now: Navigating the Precision Revolution in Oncology Treatment
5.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
From Guidelines to Practice: Hematology
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation